The patents at dispute here are not "Copolymer being used to treat MS" which is the 1972 patent
the patents at dispute here are "Copolymer with less molecular weight are less toxic"
it seems like a Novel finding (it's another matter that the patent was issued based on falsehoods...which is why you have inequitable conduct to invalidate)